Resistance to chemotherapy mediated by TrkB in neuroblastomas. - Wikidata - wikimedia - TriplyDB

Resistance to chemotherapy mediated by TrkB in neuroblastomas.

Resistance to chemotherapy mediated by TrkB in neuroblastomas.

http://www.wikidata.org/entity/Q44220743

about

Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?Tropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancer A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma Genome-wide analysis of miRNA signature differentially expressed in doxorubicin-resistant and parental human hepatocellular carcinoma cell lines Cell Surface Protein Detection to Assess Receptor Internalization Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth Inhibition of focal adhesion kinase and src increases detachment and apoptosis in human neuroblastoma cell lines Myc proteins as therapeutic targets.Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.Ciliary neurotrophic factor reduces the proliferation and promotes the differentiation of TH- MYCN transformed sympathoadrenal progenitors.Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing program.SPARC overexpression inhibits cell proliferation in neuroblastoma and is partly mediated by tumor suppressor protein PTEN and AKT.Inhibition of uterine sarcoma cell growth through suppression of endogenous tyrosine kinase B signaling.Heat shock protein 90 inhibition depletes TrkA levels and signaling in human acute leukemia cells.Novel agents targeting the IGF-1R/PI3K pathway impair cell proliferation and survival in subsets of medulloblastoma and neuroblastoma.Endogenous repair by the activation of cell survival signalling cascades during the early stages of rat Parkinsonism.Trk receptor expression and inhibition in neuroblastomas Therapeutic targets for neuroblastomas.Rotary bioreactor culture can discern specific behavior phenotypes in Trk-null and Trk-expressing neuroblastoma cell lines.HBZ stimulates brain-derived neurotrophic factor/TrkB autocrine/paracrine signaling to promote survival of human T-cell leukemia virus type 1-Infected T cells Role and relevance of TrkB mutations and expression in non-small cell lung cancer.Bcl-2 inhibitor HA14-1 and genistein together adeptly down regulated survival factors and activated cysteine proteases for apoptosis in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells Differential roles of Trk and p75 neurotrophin receptors in tumorigenesis and chemoresistance ex vivo and in vivo Quantitative phosphoproteomic analysis identifies activation of the RET and IGF-1R/IR signaling pathways in neuroblastoma.Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention.Sunitinib suppress neuroblastoma growth through degradation of MYCN and inhibition of angiogenesis Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapy.Nifurtimox induces apoptosis of neuroblastoma cells in vitro and in vivo Clinical significance of NTRK family gene expression in neuroblastomas Testing of the Akt/PKB inhibitor MK-2206 by the Pediatric Preclinical Testing Program.Targeting MYCN IRES in MYCN-amplified neuroblastoma with miR-375 inhibits tumor growth and sensitizes tumor cells to radiation A distinct gene expression signature characterizes human neuroblastoma cancer stem cells.BMCC1, which is an interacting partner of BCL2, attenuates AKT activity, accompanied by apoptosis.Differential aminoacylase expression in neuroblastoma.Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology Morphological Differentiation Towards Neuronal Phenotype of SH-SY5Y Neuroblastoma Cells by Estradiol, Retinoic Acid and Cholesterol.MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.mda-7/IL-24 Induces Cell Death in Neuroblastoma through a Novel Mechanism Involving AIF and ATM.

P2860

Q26750898-4093EF42-9478-4021-8E2C-4965DCF2CF07 Q26774713-C5305C4F-EFD5-4F15-B403-1E4E733AB4A2 Q28479007-33ED6F14-D1A0-4129-A5FF-0C6ACA07E059 Q28485293-2FE30310-6AF4-48A6-A2DA-85882D2A3AD4 Q33560957-C73BF3A0-46F7-49B5-87A7-EFF717031A35 Q33631442-C6D469E4-9BD8-4ED3-B5E2-51EB28E297DE Q33768039-7AEBB77A-AF10-4EE1-8891-73DA5C2252A9 Q33997741-BC49FF5A-4120-4D13-8FBA-8FF93E65376A Q34055511-E1647CAE-0DE8-4639-B869-001341612563 Q34243956-B1493DD7-1515-4ED4-9156-D2CA0D50D63D Q34249719-EC8C1111-D215-4917-A67B-D8F4F95ED092 Q34261684-CFE70215-CC74-48BF-9F96-E472BAD2100E Q34387629-32FAF027-BA2B-48F1-9666-6CB37DD0E07E Q34433002-E85FFA84-A210-417B-9268-BE387C125D31 Q34442835-4C01DE2C-8E9D-4D48-8EB6-ED61C16495F8 Q34516390-8BE7BAA0-9A2A-42FC-B405-694AF8B36FFF Q34549157-4CBD0C63-ADF5-4026-9112-133ACD02C615 Q34560877-0C832B00-4A10-4018-9AA2-59B3C388D3DC Q34569243-4EBC104E-4EDB-4120-82E5-8D8D002FFBAD Q34594557-D2F37B49-2BD4-432C-BEB3-5C2BCD5DF65A Q34917434-ABFA8B66-F496-4989-B269-F9A2F49887A3 Q35013101-6EB07C96-7393-4752-8501-1DF498EE4D0D Q35042689-10A2D904-27AF-475F-90F3-B7E3E83E8219 Q35070321-13362331-BA16-48F8-9DC4-5FDC18461CBA Q35097218-5C3DE3BA-6968-430A-8365-A83B21FA7607 Q35111170-07934101-441B-4E41-8C00-9796B128D40C Q35127189-C7FE409D-3919-496E-BF8B-C1B27CCB2C14 Q35156047-4C9A3A40-F58F-43EF-89A0-7DB04E38537A Q35182759-3355E395-DBFC-4012-AF45-8F4D50808B8E Q35652431-AB0B3D42-1266-4EA6-8361-9157DEFB41CA Q35673178-8C84A890-6357-4B43-8759-12A65E30B046 Q35791105-22405F40-D3BD-4D1A-B2F6-C60EC64E7037 Q35912185-BAA706CD-DC17-4422-99C0-F7A599B6F5EA Q36148130-53227039-2E6E-42C3-8484-C0D2E4991DC0 Q36347152-2EA22D6E-0C82-4259-95BA-17B341470391 Q36477194-4F4147DC-25F3-46A7-A4C6-BC3D0EB1A5DB Q36586203-2A3BC1C8-B36D-45D4-985D-27F412CA8EF7 Q36778207-A739C7A3-97AC-47B7-9ECA-785A0630C4A2 Q36962575-6EEBEE3A-F346-41BC-B106-F1C68AF3A735 Q37014165-459600C6-3AA4-4C65-99B9-4006E675A398

P2860

Resistance to chemotherapy mediated by TrkB in neuroblastomas.

http://www.wikidata.org/entity/Q44220743

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Resistance to chemotherapy mediated by TrkB in neuroblastomas.

@en

Resistance to chemotherapy mediated by TrkB in neuroblastomas.

@nl

type

label

Resistance to chemotherapy mediated by TrkB in neuroblastomas.

@en

Resistance to chemotherapy mediated by TrkB in neuroblastomas.

@nl

prefLabel

Resistance to chemotherapy mediated by TrkB in neuroblastomas.

@en

Resistance to chemotherapy mediated by TrkB in neuroblastomas.

@nl

P1433

Q44220743-09B260EA-80A5-4DDB-84C7-28100F645883

P1476

Q44220743-03F14846-09EF-434B-ACD8-227A7F2A5943

P2093

Q44220743-046AADE6-055A-41D5-950B-2B40F93238DD

Q44220743-536F6030-1C06-4C63-8903-7A6C2E52D62B

Q44220743-5A73EF8B-755C-4D25-B3CD-CA432DC59F58

Q44220743-94C8EEB2-3349-4DC7-8A63-E0C64ED7F983

Q44220743-BA685267-B670-48DD-902A-6AF0364B817F

Q44220743-F436D8EF-C435-4BAF-AF1C-91EA656A913C

Q44220743-F50329FF-DBD2-45C4-94E7-BD907AB01D64

Q44220743-F74D9874-7A55-48E6-9913-CC4E24719B45

Q44220743-FC58C94A-C2BB-4537-929D-D9935341B097

P304

Q44220743-78B2DC94-CE05-43C8-B2D7-9B21E92F992D

P31

Q44220743-7F6F0FD4-DFDB-4B63-8FE4-BBF80D5358DF

P407

Q44220743-12B2B6F9-E8DD-4CC7-950D-D21BC4A1E9D9

P433

Q44220743-C2419634-C0CC-4F6C-B60D-B35B0C01A255

P478

Q44220743-8D84612C-998D-4410-8C52-2A412FEBCF3F

P577

Q44220743-0581FC33-FC51-4A94-BCE0-E0896AC259D6

P698

Q44220743-58BFAA9D-F7C5-4E7E-853C-0305772E7BB5

P921

Q44220743-1DCC17E4-BE39-45B0-B44D-F793BF0D76E5

P1433

Cancer Research

P1476

Resistance to chemotherapy mediated by TrkB in neuroblastomas

@en

P2093

Angelika Eggert

http://www.w3.org/2001/XMLSchema#string

Anna Marie Camoratto

http://www.w3.org/2001/XMLSchema#string

Audrey E Evans

http://www.w3.org/2001/XMLSchema#string

Garrett M Brodeur

http://www.w3.org/2001/XMLSchema#string

Jane E Minturn

http://www.w3.org/2001/XMLSchema#string

Naohiko Ikegaki

http://www.w3.org/2001/XMLSchema#string

Patricia Foster

http://www.w3.org/2001/XMLSchema#string

Ruth Ho

http://www.w3.org/2001/XMLSchema#string

Tomoro Hishiki

http://www.w3.org/2001/XMLSchema#string

P304

6462-6466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12438236

http://www.w3.org/2001/XMLSchema#string

P921